PHARMACOR CYPROTERONE 50 cyproterone acetate 50mg tablet blister pack

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Kjøp det nå

Last ned Preparatomtale (SPC)
25-03-2021

Aktiv ingrediens:

cyproterone acetate

Tilgjengelig fra:

Cipla Australia Pty Ltd

Autorisasjon status:

Registered

Informasjon til brukeren

                                Pharmacor Cyproterone 50
1
PHARMACOR CYPROTERONE 50
CONSUMER MEDICINE INFORMATION (CMI) SUMMARY
The full CMI on the next page has more details. If you are worried
about using this medicine, speak to your doctor or pharmacist.
1.
WHY AM I USING PHARMACOR CYPROTERONE 50?
Pharmacor Cyproterone 50 contains the active ingredient cyproterone
acetate. Pharmacor Cyproterone 50 may slow or stop
the growth of cancer and also used to reduce abnormal sex drive in
men. Pharmacor Cyproterone 50 tablets may slow or stop
excessive hairiness, loss of scalp hair, acne, oily skin and dandruff.
For more information, see Section 1. Why am I using Pharmacor
Cyproterone 50? in the full CMI.
2.
WHAT SHOULD I KNOW BEFORE I USE PHARMACOR CYPROTERONE 50?
Do not use if you have ever had an allergic reaction to cyproterone
acetate or any of the ingredients listed at the end of the
CMI. Do not take this medicine if you are pregnant or suspect you may
be pregnant. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER
MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE PREGNANT OR PLAN
TO BECOME PREGNANT OR ARE BREASTFEEDING. For more
information, see Section 2. What should I know before I use Pharmacor
Cyproterone 50? in the full CMI.
3.
WHAT IF I AM TAKING OTHER MEDICINES?
Some medicines may interfere with Pharmacor Cyproterone 50 and affect
how it works. A list of these medicines is in Section
3. What if I am taking other medicines? in the full CMI.
4.
HOW DO I USE PHARMACOR CYPROTERONE 50?
•
The usual daily dose is 50‐300 mg of Pharmacor Cyproterone 50
tablets. Your doctor will advise of the most suitable dose
for you to take. Follow all directions given to you by your doctor or
pharmacist carefully.
More instructions can be found in Section 4. How do I use Pharmacor
Cyproterone 50? in the full CMI.
5.
WHAT SHOULD I KNOW WHILE USING PHARMACOR CYPROTERONE 50?
THINGS YOU
SHOULD DO
•
Remind any doctor, dentist or pharmacist when you visit that you are
using Pharmacor Cyproterone
50.
•
Your doctor will check your red‐blood cell count to ensure y
                                
                                Les hele dokumentet
                                
                            

Preparatomtale

                                AUSTRALIAN PRODUCT INFORMATION - PHARMACOR CYPROTERONE 50
(CYPROTERONE ACETATE) 50 MG TABLETS
1
NAME OF THE MEDICINE
Cyproterone acetate
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pharmacor Cyproterone 50 tablets
Each tablet contains 50 mg cyproterone acetate
Excipient with known effects
Contains lactose
For the full list of excipients, see section 6.1 List of excipients.
3
PHARMACEUTICAL FORM
White circular flat bevelled tablets, with breakline on one side and
plain on the other.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
WOMEN

Moderately severe to severe signs of androgenisation

moderately severe/severe forms of hirsutism

moderately severe/severe androgen-dependent loss of scalp hair
(moderately severe/severe
androgenic alopecia)

moderately severe/severe forms of acne and/or seborrhoea associated
with other features of
androgenisation
Cyproterone acetate inhibits the influence of male sex hormones, which
are also produced by the
female. It is thus possible to treat diseases in women caused either
by increased production of
androgens or a particular sensitivity to these hormones. Hirsutism and
alopecia may be expected to
recur over a period of time after cessation of treatment.
If Pharmacor Cyproterone 50 is taken during pregnancy, the properties
of the preparation may lead to
signs of feminisation in the male foetus. Therefore, in women of child
bearing potential, pregnancy
must be excluded at the commencement of treatment and ethinyl
oestradiol taken as well to ensure
contraception. This also promotes regular menstruation.
MEN
REDUCTION OF DRIVE IN SEXUAL DEVIATIONS
Pharmacor Cyproterone 50 reduces the force of the sexual urge in men
with sexual deviations. Whilst
under treatment, the man can control himself better in a predisposing
stimulatory situation, but there is
no influence on any deviating direction of sexual drive. Abnormal
patterns of sexual behaviour
require treatment when they are distressing to the patient. A
prerequisite for therapy is the desire by
the patient for treatme
                                
                                Les hele dokumentet
                                
                            

Søk varsler relatert til dette produktet